Publication | Closed Access

Development and in vitro-in vivo performances of an inhalable indole-3-carboxaldehyde dry powder to target pulmonary inflammation and infection

AsthmaInflammationLung DepositionInflammatory Lung DiseasePulmonary InflammationLung InflammationMedicineRespiratory ToxicologyImmunologyPulmonary PharmacologyInfectious Respiratory DiseasePharmacologyVitro-in Vivo PerformancesInhalation Toxicology